Irish marketing-authorisation holder for biosimilar medicines, registered at Baldoyle Industrial Estate in Dublin. It holds European authorisations for biosimilars including bevacizumab, denosumab, pegfilgrastim, insulin aspart, etanercept and insulin glargine.
No comments available.
Leave your rating & comment